Epidermodysplasia Verruciformis:A Rare Disoder with a Rarer Incidence in Indian Population.
Abstract
Full Text:
PDFReferences
Sehgal VN, Luthra A, Bajaj P. Epidermodysplasia verruciformis: 14 members of a pedigree with an intriguing Squamous cell carcinoma transformation report. Int J Dermatol 2002;41:500-3. [PUBMED]
Yoshida R, Kato T, Kawase M, Honda M, Mitsuishi T. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report. BMC Dermatol. 2014 Jul 21. 14(1):12. [Medline].
Highet AS, Kurtz J . Viral Infections, In: Textbook of Dermatology ( Champion RH , Burton JL, Ebling FJG, eds), 5th edition. Oxford : Blackwell Scientific, 1992; 914-6.
de Sá NB, Guerini MB, Barbato MT, Di Giunta G, Nunes DH. Epidermodysplasia verruciformis: clinical presentation with varied forms of lesions. An Bras Dermatol 2011; 86(4 suppl 1): 57-60. [PubMed]
de Oliveira WR, et al. Clinical aspects of epidermodysplasia verruciformis. J EurAcad DermatolVenereol 2003; 17(4): 394-398. [ubMed]
Sri J, Dubina M, Kao G, Rady P, Tyrking S, Gaspari A. Generalized Verrucosis: A Review of the associated diseases, evaluation, and treatments. J Am AcadDermatol 2012; 66(2): 292- 311. [PubMed]
Patel T, Morrison K, Rady P, Tyring S. Epidermodysplasia verruciformis and susceptibility to HPV. Disease Markers 2010; 29: 199-206. [PubMed]
Androphy EJ, Dvoretzky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol. 1985 Jul. 121(7):864-8. [Medline].
www.orpha.net/rare diseases/ Epidermodysplasia verruciformis
Majewski S, Skopinska M, Bollag W, Jablonska S. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet. 1994 Nov 26. 344(8935):1510-1. [Medline].
Vohra S, Shama NL, Shanker V, Mahajan VK, Jindal N. Autosomal dominant epidermodysplasia verruciformis: A clinicotherapeuticexpeince in two cases. Indian JDerma to lV enereol Lepol 2010;76:557-61
Shah BH, Jalan VD. Review of literature of epidermodysplasia verruciformis with 2 case reports. Indian J DermatolVenereolLeprol 1971;37:16-8.
Singh OP, Nayyar KC. Epidermodysplasia verruciformis. Indian J DermatolVenereolLeprol 1973;39:26-8.
Vasishtha LK. Condylomataaccuminata like lesions in epidermodysplasia verruciformis. Indian J Derma to lV enereol Leprol 1981;47:229-31.
Sharma VK, Kaur S, Kumar B, Sehgal S. Epidermodysplasia verruciformis with squamous cell carcinoma in a family. Indian J DermatolVenereolLeprol 1985;51:80-6.
Bandyopadhyay D. Epidermodysplasia verucciformis with multiple squamous cell carcinomata. Indian J Dermatol 1995;40:102-3.
Grover S, Sayal SK, Singh G, Dash K. Epidermodysplasia verruciformis. Indian J DermatolVenereolLeprol 1996;62:61.
Ramesh A, Krishanan SG, Jayaraman M, Janaki VR, Boopalraj JM. Epidermodysplasia verruciformis. Indian J DermatolVenereolLeprol 1997;63:238-40.
Kuruvilla M, Raghuveer CV, Rao GS, Sridhar KS, Kumar P. Epidermodysplasia verruciformis with bowenoid changes. Indian J DermatolVenereolLeprol 1998;64:195-6.
Sentamilselvi G, Lakshmi S, Sampath V, Janki C, Janaki VR. Epidermodysplasia verruciformis with vulvalbowen's disease. Indian J Dermatol 2001;46:161-2.
Karthikeyan K, Thappa DM, Ghotekar LH. Epidermodysplasia verruciformis with HIV infection. Indian J Dermatol 2004;49:160-1.
Padmavathy L, Lakshmana RL, Ethirajan N, Krishnaswamy B, Manohar U. Epidermodysplasia verruciformis with Hansen's disease, Herpes simplex labialis and multiple eccrinehidradenoma. Indian J Dermatol 2009;54:S53-6.
Rogers HD, Macgregor JL, Nord KM, et al. Acquired epidermodysplasia verruciformis. J Am AcadDermatol 2009; 60(2): 315-320. [PubMed]
Gober MD, Rady PL, He Q, Tucker SB, Tyring SK, Gaspari AA. Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient. J Invest Dermatol. 2007 Apr. 127(4):817-20.
Sun XK, Chen JF, Xu AE. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. ClinExpDermatol. 2005 Sep. 30(5):573-4.
Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med. 2008 Jan 21. 205(1):35-42.
McDermott DF, Gammon B, Snijders PJ, et al. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. PediatrDermatol. 2009 May-Jun. 26(3):306-10.
Crequer A, Troeger A, Patin E, Ma CS, Picard C, Pedergnana V, et al. Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections. J Clin Invest. 2012 Sep. 122 (9):3239-47.
Crequer A, Picard C, Patin E, D'Amico A, Abhyankar A, Munzer M, et al. Inherited MST1 deficiency underlies susceptibility to EV-HPV infections. PLoS One. 2012. 7 (8):e44010.
Li SL, Duo LN, Wang HJ, Dai W, Zhou EH, Xu YN, et al. Identification of the LCK mutation in an atypical epidermodysplasia verruciformis family with T cell defects and virus-induced squamous cell carcinoma. Br J Dermatol. 2016 Apr 18.
de Koning M, Struijk L, Feltkamp M, ter Schegget J. HPV DNA detection and typing in inapparent cutaneous infections and premalignant lesions. Methods Mol Med. 2005. 119:115-27.
Nuovo G, Ishag M. The Histologic Spectrum of Epidermodysplasia Verruciformis. The American Journal of Surgical Pathology 2000; 24(10): 1400-1406. [PubMed]
Anadolu R, Oskay T, Erdem C, Boyvat A, Terzi E, Gurgey E. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a. J Am Acad Dermatol. 2001 Aug. 45(2):296-9.
Gubinelli E, Posteraro P, Cocuroccia B, Girolomoni G. Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin. J Dermatolog Treat. 2003 Sep. 14(3):184-8. .
Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol. 1995 Nov. 131(11):1312-8.
Hoffner MV, Camacho FM. Surgical treatment of epidermodysplasia verruciformis. Dermatol Surg. 2010 Mar. 36(3):363-7.
Partridge ME, Pariser RJ. Ocular and cutaneous squamous cell carcinoma in an African American man with epidermodysplasia verruciformis resulting in blindness and death. J Am Acad Dermatol. 2003 Nov. 49(5 Suppl):S262-4.
Nuovo G, Ishag M. The Histologic Spectrum of Epidermodysplasia Verruciformis. The American Journal of Surgical Pathology 2000; 24(10): 1400-1406. [PubMed]
Majewski S, Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Arch Dermatol 2002; 138(5): 649-654. [PubMed]
Segura S, Carrera C,Ferrando J, et al. Dermascopy in epidermodysplasia verruciformis. Dermatol Surg 2006;32:103-6.
Mitsuishi T, Kawana S, Kato T, Kawashima M. Human papillomavirus infection in actinic keratosis and bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21(Waf1/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions. Hum Pathol. 2003 Sep. 34(9):886-92.
Stetsenko GY, McFarlane RJ, Chien AJ, et al. Subungual Bowen disease in a patient with epidermodysplasia verruciformis presenting clinically as longitudinal melanonychia. Am J Dermatopathol. 2008 Dec. 30(6):582-5.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University